| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |